Ftse Mib
36.301,63
1,35%
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
104.320,77
4,31%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CytoSorbents Corporation (CTSO) CytoSorbents Corporation (CTSO) Notizie

CytoSorbents Corporation

CTSO
1,03
-0,01 (-0,96%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:26:37
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202515:05EDGAR2Form 8-K - Current report
13/1/202513:00GLOBECytoSorbents Strengthens Balance Sheet with Closing of..
07/1/202519:26EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
06/1/202522:31EDGAR2Form 8-K - Current report
06/1/202513:00GLOBECytoSorbents Expands Global Footprint with Opening of New..
03/1/202513:00GLOBECytoSorbents Reports Preliminary Unaudited Fourth Quarter..
23/12/202422:05EDGAR2Form 8-K - Current report
23/12/202413:00GLOBECytoSorbents Rights Offering Begins
16/12/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202413:00GLOBECytoSorbents to Host Investor Meetings in San Francisco..
09/12/202413:18EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
09/12/202413:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/12/202413:08EDGAR2Form 8-K - Current report
09/12/202413:00GLOBECytoSorbents Announces Rights Offering
26/11/202413:00GLOBECytoSorbents to Participate at the Piper Sandler 36th Annual..
11/11/202413:30GLOBECytoSorbents And Converge Biotech Announce Strategic..
07/11/202422:10EDGAR2Form 8-K - Current report
07/11/202422:05GLOBECytoSorbents Reports Third Quarter 2024 Financial and..
04/11/202413:00GLOBECytoSorbents Submits Health Canada Medical Device License..
22/10/202413:00GLOBEFDA Accepts DrugSorb-ATR De Novo Application To Reduce the..
17/10/202413:00GLOBECytoSorbents to Report Third Quarter 2024 Operating and..
09/10/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202423:25EDGAR2Form 8-K - Current report
01/10/202423:22EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/10/202414:06EDGAR2Form 8-K - Current report
01/10/202413:00GLOBECytoSorbents Submits DrugSorb-ATR Marketing Application to..
26/9/202423:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
27/8/202413:00GLOBECytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual..
20/8/202422:51EDGAR2Form 8-K - Current report
17/8/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202400:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/8/202423:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/8/202423:12EDGAR2Form 8-K - Current report
16/8/202422:05GLOBECytoSorbents Announces Inducement Grants Under Nasdaq..
13/8/202422:19GLOBECytoSorbents Reports Second Quarter 2024 Financial and..
13/8/202422:18GLOBECytoSorbents Appoints Peter J. Mariani Chief Financial..
13/8/202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:00GLOBECytoSorbents to Report Second Quarter 2024 Operating and..
01/8/202422:12EDGAR2Form 8-K - Current report
01/8/202413:00GLOBECytoSorbents Announces Compliance with Nasdaq Minimum Bid..
29/7/202414:00GLOBECytoSorbents Unveils Newly Redesigned, Unified Company and..
26/7/202423:14EDGAR2Form S-3 - Registration statement under Securities Act of..
26/7/202423:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/7/202413:00GLOBECytoSorbents to Present at the Inaugural American..
02/7/202413:00GLOBECytoSorbents Secures $20 Million Credit Facility
24/6/202413:00GLOBECytoSorbents Announces Regulatory Approval of CytoSorb® in..
13/6/202413:00GLOBECytoSorbents Announces the Launch and Immediate Availability..
10/6/202422:31EDGAR2Form 8-K - Current report
Apertura: 1,01 Min: 1,01 Max: 1,0396
Chiusura: 1,04

La tua Cronologia

NASDAQ
CTSO
CytoSorbents
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network